{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:23:51Z","timestamp":1794569031935,"version":"4.9.1"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.metop.2025.100399","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:46:59Z","timestamp":1758829619000},"page":"100399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Berberine's impact on health: Comprehensive biological, pharmacological, and nutritional perspectives"],"prefix":"10.1016","volume":"28","author":[{"given":"Parastoo","family":"Asghari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-263X","authenticated-orcid":false,"given":"Arvin","family":"Babaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Zamanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-716X","authenticated-orcid":false,"given":"Elyas Nattagh-","family":"Eshtivani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1213","article-title":"Berberine: a natural modulator of immune cells in multiple sclerosis","volume":"12","author":"Yazdanpanah","year":"2024","journal-title":"Immun Inflamm Dis"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ptr.7312","article-title":"Biological and pharmacological effects and nutritional impact of phytosterols: a comprehensive review","volume":"36","author":"Nattagh\u2010Eshtivani","year":"2022","journal-title":"Phytother Res"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biology12070973","article-title":"Berberine and its study as an antidiabetic compound","volume":"12","author":"Utami","year":"2023","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/13880209.2023.2248167","article-title":"Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials","volume":"61","author":"Qiao","year":"2023","journal-title":"Pharm Biol"},{"key":"10.1016\/j.metop.2025.100399_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1187718","article-title":"Berberine influences multiple diseases by modifying gut microbiota","volume":"10","author":"Yang","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.metop.2025.100399_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib8","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.metop.2025.100399_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and its role in chronic disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"10.1016\/j.metop.2025.100399_bib10","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1517\/13543784.2010.517745","article-title":"Berberine: a potential phytochemical with multispectrum therapeutic activities","volume":"19","author":"Vuddanda","year":"2010","journal-title":"Expet Opin Invest Drugs"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.metop.2025.100399_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jpba.2007.03.022","article-title":"Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry","volume":"44","author":"Hua","year":"2007","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib15","first-page":"516","article-title":"Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review","volume":"20","author":"Rad","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.metop.2025.100399_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1034\/j.1600-0773.2002.t01-1-910403.x","article-title":"The involvement of P-glycoprotein in berberine absorption","volume":"91","author":"Pan","year":"2002","journal-title":"Pharmacol Toxicol"},{"issue":"10","key":"10.1016\/j.metop.2025.100399_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metop.2025.100399_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpba.2015.07.031","article-title":"Pharmacokinetics in rats and tissue distribution in mouse of berberrubine by UPLC-MS\/MS","volume":"115","author":"Wang","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.metop.2025.100399_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2015.05.068","article-title":"Current knowledge and pharmacological profile of berberine: an update","volume":"761","author":"Kumar","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib21","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ptr.6252","article-title":"Berberine and barberry (Berberis vulgaris): a clinical review","volume":"33","author":"Imenshahidi","year":"2019","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.metop.2025.100399_bib22","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1002\/jps.23718","article-title":"Excretion of berberine and its metabolites in oral administration in rats","volume":"102","author":"Ma","year":"2013","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.metop.2025.100399_bib23","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/ptr.7996","article-title":"The effect of propolis supplementation on cardiovascular risk factors in women with rheumatoid arthritis: a double\u2010blind, placebo, controlled randomized clinical trial","volume":"37","author":"Maddahi","year":"2023","journal-title":"Phytother Res"},{"issue":"25","key":"10.1016\/j.metop.2025.100399_bib24","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019","volume":"76","author":"Roth","year":"2020","journal-title":"JACC (J Am Coll Cardiol)"},{"key":"10.1016\/j.metop.2025.100399_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100385","article-title":"Helicobacter pylori infection and association with chronic diseases: a focus on cardiovascular disease, MASLD, and type 2 diabetes","volume":"27","author":"Maleki","year":"2025","journal-title":"Metabolism Open"},{"issue":"12","key":"10.1016\/j.metop.2025.100399_bib26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib27","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1039\/C7FO00178A","article-title":"Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach","volume":"8","author":"Cicero","year":"2017","journal-title":"Food Funct"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp078","article-title":"Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase","volume":"82","author":"Wang","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14712598.2013.776037","article-title":"Effects of berberine on lipid profile in subjects with low cardiovascular risk","volume":"13","author":"Derosa","year":"2013","journal-title":"Expet Opin Biol Ther"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ptr.6282","article-title":"Metabolic effect of berberine\u2013silymarin association: a meta\u2010analysis of randomized, double\u2010blind, placebo\u2010controlled clinical trials","volume":"33","author":"Fogacci","year":"2019","journal-title":"Phytother Res"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib31","doi-asserted-by":"crossref","first-page":"H1227","DOI":"10.1152\/ajpheart.00612.2020","article-title":"Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease","volume":"319","author":"Lewis","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218384","article-title":"Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy","volume":"14","author":"Feng","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","article-title":"Role of gut microbiota in atherosclerosis","volume":"14","author":"Jonsson","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"10.1016\/j.metop.2025.100399_bib34","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.metop.2025.100399_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2017.11.023","article-title":"Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe\u2212\/\u2212 mice","volume":"268","author":"Zhu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"19","key":"10.1016\/j.metop.2025.100399_bib37","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1080\/10408398.2018.1517725","article-title":"A next generation probiotic, Akkermansia muciniphila","volume":"59","author":"Zhai","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.metop.2025.100399_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2017.00042","article-title":"Berberine attenuates intestinal mucosal barrier dysfunction in type 2 diabetic rats","volume":"8","author":"Gong","year":"2017","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/JOE-13-0184","article-title":"Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats","volume":"218","author":"Shan","year":"2013","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib40","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3892\/mmr.2017.6321","article-title":"Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels","volume":"15","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2024.5373","article-title":"Berberine inhibits excessive autophagy and protects myocardium against ischemia\/reperfusion injury via the RhoE\/AMPK pathway","volume":"53","author":"Hu","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.metop.2025.100399_bib43","first-page":"2356","article-title":"Cardioprotection is alive but remains enigmatic: the nitric oxide\u2013protein kinases\u2013mitochondria signaling axis","author":"Heusch","year":"2017","journal-title":"Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib44","first-page":"452","article-title":"Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion","volume":"34","author":"Zheng","year":"2003","journal-title":"Sichuan da xue xue bao Yi xue ban= Journal of Sichuan University Medical Science Edition"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib45","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/molecules27041351","article-title":"Berberine, a herbal metabolite in the metabolic syndrome: the risk factors, course, and consequences of the disease","volume":"27","author":"Och","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib47","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.M114.597229","article-title":"Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin-proteasome degradation pathway","volume":"290","author":"Dong","year":"2015","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.metop.2025.100399_bib48","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.metop.2025.100399_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0629-3","article-title":"Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters","volume":"13","author":"Li","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.metop.2025.100399_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117277","article-title":"Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR\/P70S6K\/4EBP1 pathway","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci"},{"issue":"1\u20132","key":"10.1016\/j.metop.2025.100399_bib51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellimm.2012.04.006","article-title":"Berberine induces peripheral lymphocytes immune regulations to realize its neuroprotective effects in the cerebral ischemia\/reperfusion mice","volume":"276","author":"Song","year":"2012","journal-title":"Cell Immunol"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib52","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine","volume":"93","author":"Zhang","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.metop.2025.100399_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-11-86","article-title":"The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet","volume":"11","author":"Chang","year":"2012","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/s12349-010-0043-6","article-title":"Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet","volume":"4","author":"Trimarco","year":"2011","journal-title":"Mediterr J Nutr Metabol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52253-y","article-title":"Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice","volume":"9","author":"Singh","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metop.2025.100399_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0628-x","article-title":"Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats","volume":"16","author":"Zhou","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib57","first-page":"369","article-title":"Effects of the traditional Chinese medicine berberine on antiatheroscloresis and antioxidant activities in hyperlipoidemic model rats","volume":"33","author":"Zhu","year":"2017","journal-title":"Zhongguo Ying Yong Sheng li xue za zhi= Zhongguo Yingyong Shenglixue Zazhi= Chinese Journal of Applied Physiology"},{"issue":"9","key":"10.1016\/j.metop.2025.100399_bib58","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2014.05.013","article-title":"Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption","volume":"63","author":"Wang","year":"2014","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0035-1568261","article-title":"Hypolipidemic effects of alkaloids from Rhizoma Coptidis in diet-induced hyperlipidemic hamsters","volume":"82","author":"He","year":"2016","journal-title":"Planta Med"},{"issue":"2\u20133","key":"10.1016\/j.metop.2025.100399_bib60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejphar.2011.03.024","article-title":"Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats","volume":"660","author":"Dong","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib61","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMPK with beneficial metabolic effects in diabetic and insulin resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.112.252932","article-title":"Upregulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamsters","volume":"33","author":"Briand","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.2003176","article-title":"Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study","volume":"14","author":"Wang","year":"2022","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pcn.13323","article-title":"Adjunctive berberine reduces antipsychotic\u2010associated weight gain and metabolic syndrome in patients with schizophrenia: a randomized controlled trial","volume":"76","author":"Chan","year":"2022","journal-title":"Psychiatr Clin Neurosci"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib65","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3390\/nu13082550","article-title":"Effect of berberine on cardiovascular disease risk factors: a mechanistic randomized controlled trial","volume":"13","author":"Zhao","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/jmf.2020.0029","article-title":"Effect of berberine plus bezafibrate administration on the lipid profile of patients with mixed dyslipidemia: a pilot clinical trial","volume":"24","author":"Le\u00f3n-Mart\u00ednez","year":"2021","journal-title":"J Med Food"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib67","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3390\/ijms18071498","article-title":"Effects of a new nutraceutical formulation (berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: results from a randomized, double blind, placebo-controlled study","volume":"18","author":"Spigoni","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib68","first-page":"681","article-title":"Therapeutic effects of berberine capsule on patients with mild hyperlipidemia. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe","volume":"36","author":"Wang","year":"2016","journal-title":"zazhi= Chinese journal of integrated traditional and Western medicine"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101978","article-title":"Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial","volume":"9","author":"Sola","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.metop.2025.100399_bib70","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/09513590.2011.652250","article-title":"Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women","volume":"28","author":"Cianci","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.metop.2025.100399_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib72","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2015.02.028","article-title":"Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats","volume":"458","author":"Liu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/10641963.2014.972560","article-title":"Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats","volume":"37","author":"Guo","year":"2015","journal-title":"Clin Exp Hypertens"},{"issue":"11","key":"10.1016\/j.metop.2025.100399_bib74","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/jcmm.12645","article-title":"Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice","volume":"19","author":"Wang","year":"2015","journal-title":"J Cell Mol Med"},{"issue":"2\u20133","key":"10.1016\/j.metop.2025.100399_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0014-2999(96)00663-2","article-title":"Inhibitory effects of berberine on ATP-sensitive K+ channels in cardiac myocytes","volume":"316","author":"Wang","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/jrms.JRMS_1078_17","article-title":"Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients","volume":"23","author":"Memon","year":"2018","journal-title":"J Res Med Sci"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib77","first-page":"32","article-title":"Effect of amlodipine and berberine in mild and midrange hypertension patients complicated with hyperuricemia arthrolithiasis","volume":"22","author":"Huang","year":"2013","journal-title":"China Pharm"},{"key":"10.1016\/j.metop.2025.100399_bib78","first-page":"117","article-title":"Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension","volume":"19","author":"Trimarco","year":"2012","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.metop.2025.100399_bib79","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s00125-021-05415-5","article-title":"Defining the underlying defect in insulin action in type 2 diabetes","volume":"64","author":"Batista","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.metop.2025.100399_bib80","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.metop.2025.100399_bib81","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1248\/bpb.30.2120","article-title":"Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes","volume":"30","author":"Kim","year":"2007","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032718","article-title":"Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes","volume":"7","author":"Ong","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.metop.2025.100399_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21233","article-title":"Addressing the preventive and therapeutic perspective of berberine against diabetes","volume":"9","author":"Shrivastava","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib84","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","article-title":"Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib85","article-title":"Pharmacokinetics and pharmacological activities of berberine in diabetes mellitus treatment","volume":"2021","author":"Han","year":"2021","journal-title":"Evid base Compl Alternative Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib86","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcb.22580","article-title":"Berberine suppresses neuroinflammatory responses through AMP\u2010activated protein kinase activation in BV\u20102 microglia","volume":"110","author":"Lu","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metop.2025.100399_bib87","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fphar.2018.00782","article-title":"The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by berberine","volume":"9","author":"Ma","year":"2018","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.metop.2025.100399_bib88","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.phymed.2012.05.009","article-title":"Lipid-lowering effect of berberine in human subjects and rats","volume":"19","author":"Hu","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.metop.2025.100399_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154099","article-title":"Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db\/db mice","volume":"101","author":"Lyu","year":"2022","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib90","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ptr.6588","article-title":"Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice","volume":"34","author":"Li","year":"2020","journal-title":"Phytother Res"},{"key":"10.1016\/j.metop.2025.100399_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/rej.2017.1972","article-title":"Berberine improves diabetic encephalopathy through the SIRT1\/ER stress pathway in db\/db mice","volume":"21","author":"Li","year":"2018","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.metop.2025.100399_bib93","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.2147\/IJN.S84565","article-title":"Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db\/db mice","author":"Xue","year":"2015","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib94","article-title":"Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL\/6 mice","volume":"2015","author":"Wang","year":"2015","journal-title":"Evid base Compl Alternative Med"},{"issue":"1\u20133","key":"10.1016\/j.metop.2025.100399_bib95","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2008.12.056","article-title":"Protective effect of berberine on beta cells in streptozotocin-and high-carbohydrate\/high-fat diet-induced diabetic rats","volume":"606","author":"Zhou","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib96","first-page":"496","article-title":"Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion","volume":"25","author":"Leng","year":"2004","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib97","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12902-023-01442-y","article-title":"Efficacy and safety of HIMABERB\u00ae Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial","volume":"23","author":"Panigrahi","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib98","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib99","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1038\/s41467-021-25952-2","article-title":"Berberine is an insulin secretagogue targeting the KCNH6 potassium channel","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib100","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/nu13072373","article-title":"Effect of a new formulation of nutraceuticals as an add-on to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: a randomized controlled trial","volume":"13","author":"Sartore","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.metop.2025.100399_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-020-00344-1","article-title":"Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism","volume":"12","author":"Yan","year":"2021","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib102","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metop.2025.100399_bib103","article-title":"Advances of berberine against metabolic syndrome-associated kidney disease: regarding effect and mechanism","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib104","first-page":"495","article-title":"Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata\/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes","volume":"31","author":"Guarino","year":"2017","journal-title":"J Biol Regul Homeost Agents"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic Fatty liver disease","volume":"31","author":"Huh","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.metop.2025.100399_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5980390","article-title":"The risk factors of nonalcoholic Fatty liver disease in morbidly Obese patients undergoing bariatric surgery in Iran","volume":"2022","author":"Aghakhani","year":"2022","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.metop.2025.100399_bib109","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review","volume":"22","author":"Nie","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.metop.2025.100399_bib111","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J Transl Med"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.metop.2025.100399_bib113","first-page":"155","article-title":"The efficiency of Berberine combined with metformin in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease","volume":"7","author":"Ning","year":"2013","journal-title":"Chinese Journal of Modern Drug Application"},{"issue":"21","key":"10.1016\/j.metop.2025.100399_bib114","first-page":"3032","article-title":"Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease","volume":"36","author":"Xie","year":"2011","journal-title":"Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China Journal of Chinese Materia Medica"},{"key":"10.1016\/j.metop.2025.100399_bib115","series-title":"Effects of berberine on insulin resistance and serum adiponectin of nonalcoholic fatty liver patients","author":"Bai RuiMiao","year":"2011"},{"key":"10.1016\/j.metop.2025.100399_bib116","article-title":"The effect of berberine on lipid profile, liver enzymes, and fasting blood glucose in patients with non-alcoholic fatty liver disease (NAFLD): a randomized controlled trial","volume":"36","author":"Nejati","year":"2022","journal-title":"Med J Islam Repub Iran"},{"issue":"20","key":"10.1016\/j.metop.2025.100399_bib117","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.metop.2025.100399_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib119","first-page":"2091","article-title":"Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2\/ARE signalling pathway","volume":"17","author":"Deng","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.metop.2025.100399_bib120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib121","article-title":"Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in mice with diet-induced obesity","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib122","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3892\/etm.2021.10543","article-title":"Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR","volume":"22","author":"Chen","year":"2021","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib123","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ecl.2022.02.008","article-title":"Lipid and lipoprotein metabolism","volume":"51","author":"Feingold","year":"2022","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib124","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-2275(20)30149-8","article-title":"In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice","volume":"43","author":"Furbee","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metop.2025.100399_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107155","article-title":"SIRT1: harnessing multiple pathways to hinder NAFLD","volume":"203","author":"Tian","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metop.2025.100399_bib126","article-title":"Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice","volume":"11","author":"Wang","year":"2023","journal-title":"Gastroenterology Report"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib127","first-page":"363","article-title":"Observation of the clinical effects of berberine combined with yi-gan-ling in the treatment of metabolize syndrome with nonalcoholic steatohepatitis","volume":"19","author":"Li","year":"2015","journal-title":"Anhui Medical and Pharmaceutical Journal"},{"issue":"14","key":"10.1016\/j.metop.2025.100399_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27144523","article-title":"Anticancer effects and mechanisms of berberine from medicinal herbs: an update review","volume":"27","author":"Xiong","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.metop.2025.100399_bib129","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3389\/fphar.2019.01461","article-title":"Effects of berberine and its derivatives on cancer: a systems pharmacology review","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Pharmacol"},{"issue":"18","key":"10.1016\/j.metop.2025.100399_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27185889","article-title":"Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways","volume":"27","author":"Almatroodi","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib131","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2468-1253(19)30409-1","article-title":"Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2025.100399_bib132","first-page":"46","article-title":"Preventive effects of Berberine in the recurrence of colorectal adenoma after endoscopic resection","volume":"29","author":"Wang","year":"2020","journal-title":"Chin J Gastroenterol Hepatol"},{"key":"10.1016\/j.metop.2025.100399_bib133","series-title":"A randomized controlled trial of berberine in the prevention of recurrence after Endoscopic resection of coloretal adenomas","author":"Liu","year":"2018"},{"issue":"16","key":"10.1016\/j.metop.2025.100399_bib134","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.ejca.2008.07.040","article-title":"Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer","volume":"44","author":"Liu","year":"2008","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s12032-009-9307-8","article-title":"Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy","volume":"27","author":"Li","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.metop.2025.100399_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114617","article-title":"Efficacy and safety of berberine in preventing recurrence of colorectal adenomas: a systematic review and meta-analysis","volume":"282","author":"Fang","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metop.2025.100399_bib137","article-title":"Radiotherapy enhancing and radioprotective properties of berberine: a systematic review","author":"Raeisi","year":"2024","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib138","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0024-3205(02)02200-2","article-title":"A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species","volume":"72","author":"K\u00fcpeli","year":"2002","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib139","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1507\/endocrj.EJ18-0109","article-title":"Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis","volume":"66","author":"Liang","year":"2019","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib140","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1142\/S0192415X14500669","article-title":"Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications","volume":"42","author":"Chen","year":"2014","journal-title":"Am J Chin Med"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib141","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.pharep.2015.03.002","article-title":"Berberine and neurodegeneration: a review of literature","volume":"67","author":"Ahmed","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib142","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","article-title":"Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"36","author":"Shin","year":"2013","journal-title":"Arch Pharm Res (Seoul)"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib143","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/1547691X.2015.1058306","article-title":"Immunotoxicity induced in mice by subacute exposure to berberine","volume":"13","author":"Mahmoudi","year":"2016","journal-title":"J Immunot"},{"key":"10.1016\/j.metop.2025.100399_bib144","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fmolb.2018.00021","article-title":"Toxicological effects of berberine and sanguinarine","volume":"5","author":"Singh","year":"2018","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.metop.2025.100399_bib145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1142\/S0192415X10008548","article-title":"Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL","volume":"38","author":"Guan","year":"2010","journal-title":"Am J Chin Med"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib146","first-page":"576","article-title":"Study on the interactions of berberine displace other drug from their plasma proteins binding sites","volume":"18","author":"Tan","year":"2002","journal-title":"Chin Pharmacol Bull"},{"issue":"2","key":"10.1016\/j.metop.2025.100399_bib147","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00228-011-1108-2","article-title":"Repeated administration of berberine inhibits cytochromes P450 in humans","volume":"68","author":"Guo","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.metop.2025.100399_bib148","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1358\/mf.2006.28.1.962774","article-title":"The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers","volume":"28","author":"Xin","year":"2006","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.metop.2025.100399_bib149","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/145325","article-title":"Cyclosporine and herbal supplement interactions","volume":"2014","author":"Colombo","year":"2014","journal-title":"J Toxicol"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00228-005-0952-3","article-title":"Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study","volume":"61","author":"Wu","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib151","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1517\/14740338.2014.932348","article-title":"Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data","volume":"13","author":"Cicero","year":"2014","journal-title":"Expet Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.metop.2025.100399_bib152","first-page":"702","article-title":"[Effect of berberin hydrochloride on blood concentration of cyclosporine A in cardiac transplanted recipients]","volume":"28","author":"Huang","year":"2008","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.metop.2025.100399_bib153","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.fct.2016.08.031","article-title":"Pre-clinical toxicity of a combination of berberine and 5-aminosalicylic acid in mice","volume":"97","author":"Li","year":"2016","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib154","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s12272-014-0510-6","article-title":"Organic cation transporter-mediated drug-drug interaction potential between berberine and metformin","volume":"38","author":"Kwon","year":"2015","journal-title":"Arch Pharm Res (Seoul)"},{"issue":"10","key":"10.1016\/j.metop.2025.100399_bib155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ja.2016.15","article-title":"In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumoniae","volume":"69","author":"Zhou","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"issue":"5","key":"10.1016\/j.metop.2025.100399_bib156","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ptr.3621","article-title":"Drug-drug interactions between ketoconazole and berberine in rats: pharmacokinetic effects benefit pharmacodynamic synergism","volume":"26","author":"Zhou","year":"2012","journal-title":"Phytother Res"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib157","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/molecules21040464","article-title":"In vivo and in vitro Study on drug-drug interaction of Lovastatin and berberine from pharmacokinetic and HepG2 cell metabolism studies","volume":"21","author":"Cui","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib158","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3892\/mmr.2016.5490","article-title":"Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7\/TAM cells","volume":"14","author":"Wen","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.metop.2025.100399_bib159","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/425037","article-title":"Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges","volume":"2015","author":"Fung","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000243932","article-title":"Displacement of bilirubin from albumin by berberine","volume":"63","author":"Chan","year":"1993","journal-title":"Biol Neonate"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib161","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0254-6272(08)60055-2","article-title":"A research on the erupted fetal diseases caused by traditional Chinese drugs--discussion from the issue that Chinese goldthread rhizome is prohibited in Singapore","volume":"28","author":"Yang","year":"2008","journal-title":"J Tradit Chin Med"},{"issue":"3","key":"10.1016\/j.metop.2025.100399_bib162","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bdrb.20075","article-title":"Developmental toxicity evaluation of berberine in rats and mice","volume":"77","author":"Jahnke","year":"2006","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"9","key":"10.1016\/j.metop.2025.100399_bib163","first-page":"562","article-title":"[Influence of huanglian and berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats]","volume":"23","author":"Lin","year":"1998","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.metop.2025.100399_bib164","first-page":"33","article-title":"New oral delivery system to improve absorption of berberine: likely interaction of cationized chitosan with PG-P Pump","volume":"5","author":"Fratter","year":"2015","journal-title":"Int J Drug Deliv"},{"issue":"4","key":"10.1016\/j.metop.2025.100399_bib165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/np400607k","article-title":"Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects","volume":"77","author":"Spinozzi","year":"2014","journal-title":"J Nat Prod"},{"key":"10.1016\/j.metop.2025.100399_bib166","first-page":"167","article-title":"Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes","volume":"5","author":"Di Pierro","year":"2013","journal-title":"Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.metop.2025.100399_bib167","first-page":"516","article-title":"Preparation and evaluation of a microemulsion for oral delivery of berberine","volume":"63","author":"Gui","year":"2008","journal-title":"Pharmazie"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936825000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936825000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:19:56Z","timestamp":1765520396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936825000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":167,"alternative-id":["S2589936825000556"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2025.100399","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine's impact on health: Comprehensive biological, pharmacological, and nutritional perspectives","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2025.100399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100399"}}